Efficacy of Intraosseous Versus Intravenous Drug Administration in Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Nov 25

PMID 39583451

Authors

Godfrey Tabowei

Samuel K Dadzie

Ashique Ali Khoso

Abdallah A Riyalat

Muhammad Ali

Mohamed Ismael Mohamed Samir Ismael Atta

Calvin R Wei

Neelum Ali

Affiliations

Soon will be listed here.

Abstract

This meta-analysis compared the efficacy of intraosseous (IO) versus intravenous (IV) drug administration in out-of-hospital cardiac arrest (OHCA). We systematically searched Embase, Web of Science, PubMed, and Cochrane Library through September 20, 2024, for relevant studies. The primary outcome was favorable neurological outcome, with secondary outcomes, including survival to hospital discharge and return of spontaneous circulation (ROSC). Seventeen studies, including randomized controlled trials and observational studies, were included in the final analysis. Pooled results showed that IV access was associated with significantly better outcomes compared to IO access. Patients in the IV group had 1.73 times higher odds of favorable neurological outcomes (RR: 1.73, 95% CI: 1.32-2.27), 1.64 times higher odds of survival to hospital discharge (RR: 1.64, 95% CI: 1.27-2.12), and 1.27 times higher odds of ROSC (RR: 1.27, 95% CI: 1.16-1.40). However, significant heterogeneity was observed across studies for all outcomes. These findings suggest that IV access may be superior to IO access in improving outcomes for OHCA patients. However, the high heterogeneity and conflicting results from individual studies highlight the need for careful interpretation and further research. Factors such as ease of access, speed of establishment, and patient condition should also be considered when choosing between IV and IO routes during resuscitation. This meta-analysis underscores the importance of reassessing current guidelines and conducting more robust primary studies to optimize vascular access strategies in OHCA management.

References

Sasson C, Rogers M, Dahl J, Kellermann A . Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2010; 3(1):63-81. DOI: 10.1161/CIRCOUTCOMES.109.889576. View

Lee A, Chang Y, Chien L, Yang S, Chiang W . A comparison between intraosseous and intravenous access in patients with out-of-hospital cardiac arrest: A retrospective cohort study. Am J Emerg Med. 2024; 80:162-167. DOI: 10.1016/j.ajem.2024.04.009. View

Hsieh Y, Wu M, Wolfshohl J, DEtienne J, Huang C, Lu T . Intraosseous versus intravenous vascular access during cardiopulmonary resuscitation for out-of-hospital cardiac arrest: a systematic review and meta-analysis of observational studies. Scand J Trauma Resusc Emerg Med. 2021; 29(1):44. PMC: 7938460. DOI: 10.1186/s13049-021-00858-6. View

Holmstrom L, Reinier K, Toft L, Halperin H, Salvucci A, Jui J . Out-of-hospital cardiac arrest with onset witnessed by emergency medical services: Implications for improvement in overall survival. Resuscitation. 2022; 175:19-27. PMC: 10306322. DOI: 10.1016/j.resuscitation.2022.04.003. View

Soar J, Nolan J, Bottiger B, Perkins G, Lott C, Carli P . European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support. Resuscitation. 2015; 95:100-47. DOI: 10.1016/j.resuscitation.2015.07.016. View

Dychter S, Gold D, Carson D, Haller M . Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012; 35(2):84-91. DOI: 10.1097/NAN.0b013e31824237ce. View

Morales-Cane I, Valverde-Leon M, Rodriguez-Borrego M, Lopez-Soto P . Intraosseous access in adults in cardiac arrest: a systematic review and meta-analysis. Emergencias. 2020; 32(1):49-56. View

Nolan J, Deakin C, Ji C, Gates S, Rosser A, Lall R . Intraosseous versus intravenous administration of adrenaline in patients with out-of-hospital cardiac arrest: a secondary analysis of the PARAMEDIC2 placebo-controlled trial. Intensive Care Med. 2020; 46(5):954-962. DOI: 10.1007/s00134-019-05920-7. View

Baert V, Vilhelm C, Escutnaire J, Nave S, Hugenschmitt D, Chouihed T . Intraosseous Versus Peripheral Intravenous Access During Out-of-Hospital Cardiac Arrest: a Comparison of 30-Day Survival and Neurological Outcome in the French National Registry. Cardiovasc Drugs Ther. 2020; 34(2):189-197. DOI: 10.1007/s10557-020-06952-8. View

10.

Granfeldt A, Avis S, Lind P, Holmberg M, Kleinman M, Maconochie I . Intravenous vs. intraosseous administration of drugs during cardiac arrest: A systematic review. Resuscitation. 2020; 149:150-157. DOI: 10.1016/j.resuscitation.2020.02.025. View

11.

Loomba R, Nijhawan K, Aggarwal S, Arora R . Increased return of spontaneous circulation at the expense of neurologic outcomes: Is prehospital epinephrine for out-of-hospital cardiac arrest really worth it?. J Crit Care. 2015; 30(6):1376-81. DOI: 10.1016/j.jcrc.2015.08.016. View

12.

Vizcarra C, Clum S . Intraosseous route as alternative access for infusion therapy. J Infus Nurs. 2010; 33(3):162-74. DOI: 10.1097/NAN.0b013e3181d9c7cf. View

13.

Monaco T, Fischer M, Michael M, Hubar I, Westenfeld R, Rauch S . Impact of the route of adrenaline administration in patients suffering from out-of-hospital cardiac arrest on 30-day survival with good neurological outcome (ETIVIO study). Scand J Trauma Resusc Emerg Med. 2023; 31(1):14. PMC: 10061896. DOI: 10.1186/s13049-023-01079-9. View

14.

Nilsson F, Bie-Bogh S, Milling L, Hansen P, Pedersen H, Christensen E . Association of intraosseous and intravenous access with patient outcome in out-of-hospital cardiac arrest. Sci Rep. 2023; 13(1):20796. PMC: 10682403. DOI: 10.1038/s41598-023-48350-8. View

15.

Ko Y, Lin H, Huang E, Lee A, Hsieh M, Yang C . Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial). BMJ. 2024; 386:e079878. PMC: 11265210. DOI: 10.1136/bmj-2024-079878. View

16.

Zhang Y, Zhu J, Liu Z, Gu L, Zhang W, Zhan H . Intravenous versus intraosseous adrenaline administration in out-of-hospital cardiac arrest: A retrospective cohort study. Resuscitation. 2020; 149:209-216. DOI: 10.1016/j.resuscitation.2020.01.009. View

17.

Mody P, Brown S, Kudenchuk P, Chan P, Khera R, Ayers C . Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial. Resuscitation. 2018; 134:69-75. DOI: 10.1016/j.resuscitation.2018.10.031. View

18.

Perkins G, Couper K . Improving vasopressor use in cardiac arrest. Crit Care. 2023; 27(1):81. PMC: 9979497. DOI: 10.1186/s13054-023-04301-3. View

19.

Daya M, Leroux B, Dorian P, Rea T, Newgard C, Morrison L . Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest. Circulation. 2020; 141(3):188-198. PMC: 7009320. DOI: 10.1161/CIRCULATIONAHA.119.042240. View

20.

Brebner C, Asamoah-Boaheng M, Zaidel B, Yap J, Scheuermeyer F, Mok V . The association of intravenous vs. humeral-intraosseous vascular access with patient outcomes in adult out-of-hospital cardiac arrests. Resuscitation. 2024; 202:110360. DOI: 10.1016/j.resuscitation.2024.110360. View